Opinion|Videos|May 29, 2024

Overcoming Barriers to Better Patient Outcomes in PAH

Ronald Oudiz, MD, FACP, FACC, FCCP, discusses the challenges and limitations associated with the adoption of new treatments and the impact of emerging therapies on patient outcomes, quality of life, and disease management in the long term.

Video content above is prompted by the following questions:

  • What are the potential challenges or limitations associated with the adoption of new treatments, such as cost, access, or safety concerns?
  • How might the evolving treatment landscape for PAH impact patient outcomes, quality of life, and disease management in the long term?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo